Io Therapeutics, Inc., announces presentation of data on its RAR gamma agonist compound IRX5010 demonstrating inhibition of tumor infiltrating myeloid derived suppressor cells, promotion of tumor infiltrating T-cells, and effective tumor growth inhibition 9-11-2024, 02:51

Salsify Announces Launch of the Salsify PXM Advance Platform, AI-Propelled for the 2nd Decade of the Digital Shelf 21-02-2024, 20:00

Constellation Brands to Report Third Quarter 2026 Financial Results on January 7, 2026 After Market Close and Host Conference Call on January 8, 2026 at 10:30 AM ET 5-12-2025, 04:30